eyes
-
Valeant to Buy Bausch & Lomb for $8.7 Billion
[THE NEW YORK TIMES] Bausch & Lomb, the eye care company, agreed on Monday to sell itself to Valeant Pharmaceuticals International of…
Read More »
[THE NEW YORK TIMES] Bausch & Lomb, the eye care company, agreed on Monday to sell itself to Valeant Pharmaceuticals International of…
Read More »A donation of your choice empowers our journalists to continue the work to better inform, educate and empower you through technology and resources that you use.